Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholera Infantum

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cholera Infantum in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's7 (77.78)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, M; Dombrowsky, H; Frerichs, I; Goldmann, T; Lautenschläger, I; Sarau, J; Uhlig, S; Weiler, N; Zitta, K1
Jewell, DP; Travis, SP1
Fletcher, JR1
Giudice, A; Herbert, JM; Le Fur, G; Maffrand, JP; Manara, L; Manzoni, L1
Hawkey, CJ; Stack, WA1
Andersson, R; Börjesson, A; Sun, Z; Wang, X1
Benveniste, J; Denizot, Y; Lewin, MJ; Mignon, M; Sobhani, I; Vatier, J; Vissuzaine, C1
Hsueh, W; Sun, XM; Torre-Amione, G1
MacNaughton, WK; Wallace, JL1

Reviews

3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholera Infantum

ArticleYear
The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 50, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Cholestasis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Digestive System Physiological Phenomena; Enterocolitis, Pseudomembranous; Epithelium; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypertension, Portal; Ischemia; Microcirculation; Pancreatitis; Peptic Ulcer; Platelet Activating Factor

1994
Eicosanoids. Critical agents in the physiological process and cellular injury.
    Archives of surgery (Chicago, Ill. : 1960), 1993, Volume: 128, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Eicosanoids; Gastrointestinal Diseases; General Surgery; Humans; Lipoxygenase; Molecular Biology; Phospholipids; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Tumor Necrosis Factor-alpha

1993
Specific mediator-directed therapy for gastrointestinal diseases.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:11

    Topics: Animals; Antibodies; Cyclosporine; Cytokines; Gastrointestinal Diseases; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Leukotriene Antagonists; Lipoxygenase Inhibitors; Mice; Mice, Knockout; Oligonucleotides, Antisense; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Thromboxanes; Tumor Necrosis Factor-alpha

1997

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cholera Infantum

ArticleYear
Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Animals; Dexamethasone; Disease Models, Animal; Edema; Eicosanoids; Female; Gastrointestinal Diseases; Intestinal Mucosa; Paralysis; Platelet Activating Factor; Protective Agents; Quinidine; Rats; Vasoconstriction

2015
Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:4

    Topics: Animals; Azepines; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Diseases; Intestinal Mucosa; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Thiazoles; Triazoles

1996
Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
    The British journal of surgery, 1999, Volume: 86, Issue:3

    Topics: Animals; Capillaries; Endothelium, Vascular; Gastrointestinal Diseases; Imidazoles; Intercellular Adhesion Molecule-1; Interleukins; Leucine; Leukocytes; Lymphocyte Activation; Male; Pancreatitis; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley

1999
Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man.
    Digestive diseases and sciences, 1992, Volume: 37, Issue:10

    Topics: Adult; Clinical Enzyme Tests; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Middle Aged; Pentagastrin; Platelet Activating Factor; Regression Analysis; Secretin; Urease

1992
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    The American journal of pathology, 1990, Volume: 136, Issue:4

    Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan

1990
Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
    European journal of pharmacology, 1988, Jun-22, Volume: 151, Issue:1

    Topics: Animals; Dexamethasone; Gastrointestinal Diseases; Hemodynamics; Leukotriene B4; Male; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Stomach Ulcer

1988